Bioactive Compounds
-
BA1656 LabMol-319Summary: LabMol-319 is a potent Zika virus inhibitor. - BA6152 PD-1-IN-24Summary: Inhibitors with oral activity.
- BA1655 DB772Summary: DB772 is a bovine viral diarrhea virus inhibitor.
- BA6151 TagitanlimabSummary: Tagitanlimab has the potential to study recurrent or metastatic nasopharyngeal carcinoma (NPC).
-
N2757 Aconine - BA1654 BVDV-IN-1Summary: BVDV-IN-1 is a bovine viral diarrhea virus non-nucleoside inhibitor (NNI).
- BA6150 BMS-37Summary: BMS-37 is an immune checkpoint inhibitor.
- BA1652 ASN03576800Summary: ASN03576800 may be a potent inhibitor of Ebola virus matrix proteins during virus assembly and outgrowth.
- BA6149 TPP-1Summary: TPP-1 is a potent inhibitor of the interaction.
- BA1651 MaftivimabSummary: Maftivimab (REGN3470-3471-3479) is a lineage virus inhibitor and is a Food and Active Molecule Administration (FDA) approved agent.